Dr. Fawcett and Associates Reply

Fawcett, Jan; Scheftner, William A.; Fogg, Louis; Clark, David; Young, Michael A.; Hedeker, Don; Gibbons, Robert D.

doi:10.1176/ajp.148.8.1092-b

Cited by 27 publications

(27 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our findings lead us to set forth the hypothesis that the higher rates of suicide attempts and completed suicide among persons with BPD relative to MDD are partially mediated by the heavier comorbid anxiety disorder burden of the former. This hypothesis is congruent with the finding that the global severity of anxiety predicts suicide among inpatients following discharge from hospital (Fawcett et al, 1990).…”

Section: Relevance Of the Findings To The Differential Rates Of Suicisupporting

confidence: 84%

Differential patterns of lifetime multiple anxiety disorder comorbidity between Latino adults with bipolar I and major depressive disorders

Dilsaver¹,

Benazzi²,

Akiskal³

et al. 2008

Bulletin of the Menninger Clinic

View full text Add to dashboard Cite

Background:To determine the lifetime rates of panic disorder, obsessive-compulsive disorder (OCD), social phobia, and posttraumatic stress disorder (PTSD) among adult Latino patients with major depressive disorder (MDD) and bipolar disorder (BPD), and whether there are dose-response relationships between loading for comorbid anxiety disorders, the probability of having BPD, and attributes of severity of illness. Methods: In a public sector clinic for the indigent located in a semiclosed rural community, 187 consecutively presenting affectively ill Latino patients were evaluated by use of the Structured Clinical Interview for DSM-IV. Polarity and the lifetime prevalence of panic disorder, OCD, social phobia, and PTSD were determined. Logistic regression was used to test associations. Trends in positive predictive values (PPVs) and likelihood ratios were assessed to determine whether dose-response relationships existed between loading for comorbid anxiety disorders and the likelihood of having BPD as opposed to MDD, psychosis, suicidal ideation, and

show abstract

Section: Relevance Of the Findings To The Differential Rates Of Suicisupporting

confidence: 84%

Differential patterns of lifetime multiple anxiety disorder comorbidity between Latino adults with bipolar I and major depressive disorders

Dilsaver¹,

Benazzi²,

Akiskal³

et al. 2008

Bulletin of the Menninger Clinic

View full text Add to dashboard Cite

show abstract

“…In addition, the risk of suicide in MDD may be increased by the presence of sleep disturbances (Fawcett et al, 1990;Chellappa and Araujo, 2007) and by comorbid anxiety (Fawcett et al, 1990;Bolton et al, 2010). It is of note that the MADRS item, Suicidal Thoughts, was significantly improved by quetiapine XR 300 mg/day versus placebo at week 6. AEs relating to suicidality were reported by one and five patients in the quetiapine XR 150 and 300 mg/day groups, respectively, and by five placebo-treated patients in these two studies where patients who were felt to be an acute suicidal risk were excluded.…”

Section: Discussionmentioning

confidence: 99%

Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder

Weisler

Montgomery

Earley

et al. 2012

International Clinical Psychopharmacology

View full text Add to dashboard Cite

Prospectively planned pooled analysis evaluating the efficacy of quetiapine extended release (XR) monotherapy in major depressive disorder (MDD). Data were pooled from two 6-week, randomized, double-blind, placebo-controlled studies of quetiapine XR in outpatients with MDD. The primary endpoint was Montgomery-Åsberg Depression Rating Scale (MADRS) total score change from randomization at week 6. Other evaluations were MADRS response/remission, Hamilton Rating Scale for Anxiety, and subgroup analyses. A total of 968 patients were randomized to quetiapine XR, 150 mg/day (n=315), 300 mg/day (n=323), or placebo (n=330). The mean MADRS total score reductions from randomization were significant at week 6 with quetiapine XR, 150 mg/day (-14.7; P<0.001) and 300 mg/day (-14.7; P<0.001) versus placebo (-11.1), with significant reductions versus placebo from week 1 onward. Response rates (week 6): 52.7% (P<0.001) quetiapine XR 150 mg/day and 49.5% (P<0.001) quetiapine XR 300 mg/day versus placebo (33.0%). MADRS remission (score≤8; week 6): 23.5% (P=0.208) quetiapine XR 150 mg/day and 28.8% (P<0.01) quetiapine XR 300 mg/day versus placebo (19.4%). Quetiapine XR (both doses) significantly improved eight of 10 MADRS items versus placebo at week 6. The therapeutic effect of quetiapine XR was neither limited to nor driven by factors such as sex, age, or severity of depression. In patients with MDD, quetiapine XR (150 and 300 mg/day) monotherapy reduced depressive symptoms, with significant improvements compared with placebo from week 1 onward.

show abstract

“…Within this context, stability of subjective well-being and life satisfaction has been previously reported (e.g. Koivumaa-Honkanen et al, 2001;Koivumaa-Honkanen et al, 2000;Haight & Hendrix, 1998;Moscicki, 1995;Sorenson, 1991;Canetto, 1991;Headley, 1989;Fawcett et al, 1987;Inglehart & Rabier, 1986).…”

mentioning

confidence: 72%

Comparing Countries’ Life Satisfaction and Their Level Curve of Life Satisfaction over Time: An Analytical Framework

Bouare¹

2017

PSYCH

View full text Add to dashboard Cite

Life satisfaction or happiness is an elusive concept, making it difficult to aggregate, measure and compare at a country level. Therefore, we propose an analytical framework, which can determine life satisfaction and the level curve of life satisfaction over time in countries. We then address four countries as cases: the Netherlands, the UK, Belgium and France. The Netherlands has the highest ranking of life satisfaction by year and the level curve of life satisfaction over 1986-1995. This analytical framework allows for the direct intercession of a country's legislator on welfare issues, strengthening social cohesion that may foster country's economic development.

show abstract

Dr. Fawcett and Associates Reply

Cited by 27 publications

References 3 publications

Differential patterns of lifetime multiple anxiety disorder comorbidity between Latino adults with bipolar I and major depressive disorders

Differential patterns of lifetime multiple anxiety disorder comorbidity between Latino adults with bipolar I and major depressive disorders

Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder

Comparing Countries’ Life Satisfaction and Their Level Curve of Life Satisfaction over Time: An Analytical Framework

Contact Info

Product

Resources

About